Delivery Order SPE2DB24D2109-SPE2DB25FHXKL
Award Date 7/14/25
Potential Completion Date 7/15/25
Potential Value $68K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $5,881.89 to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg on July 28, 2025, with a completion date of July 29, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Multaq is an antiarrhythmic medication used in the treatment of cardiac arrhythmias, reflecting the pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $14,403.81 to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg on September 24, 2025, with completion expected by September 25, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is being performed at the contractor's corporate headquarters in Conshohocken, Pennsylvania. Multaq is an antiarrhythmic medication used to maintain normal heart rhythm in patients with certain...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,947.74 to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg on September 2, 2025, with completion scheduled for September 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Multaq is an antiarrhythmic medication used in the treatment of atrial fibrillation, supporting the military...
- The Defense Logistics Agency awarded a $4,266.63 delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Multaq 400 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with a completion date of June 4, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Multaq is an antiarrhythmic medication used in the treatment of atrial fibrillation, reflecting the Defense Logistics Agency's ongoing...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,368.45 for 60-tablet units of Multaq 400 mg on June 13, 2025, with completion scheduled for June 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Multaq is an antiarrhythmic medication used in cardiac care, reflecting the pharmaceutical supply requirements...
- The Defense Logistics Agency awarded a delivery order valued at $5,234.92 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-unit package). This firm fixed-price, non-set-aside contract was awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Multaq is an antiarrhythmic medication used in the management of atrial fibrillation, representing a...
- The Defense Logistics Agency awarded a delivery order valued at $11,496.80 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Multaq 400 mg tablets (60-count packages). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract calls for delivery by August 6, 2025, and performance will occur at the contractor's Conshohocken facility. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count packages) under a firm fixed-price contract valued at $3,337.56. The order was competitively awarded without set-aside provisions and is scheduled for completion by July 25, 2025. Multaq is an antiarrhythmic medication used in the treatment of atrial fibrillation, reflecting the pharmaceutical distributor's role in supplying critical medications to federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,298.24 to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg on November 14, 2025, with an ultimate completion date of November 17, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the prime contractor. The point of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Multaq is a prescription antiarrhythmic medication used to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Multaq 400 mg tablets (60-count units) with a ceiling value of $3,059.76. This is a firm fixed-price delivery order with no set-aside designation, executed competitively. The contract is performance-based with an ultimate completion date of September 30, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Multaq is...